Evaluation of the power of six clustering features in identifying a homogeneous disease subset in juvenile idiopathic arthritis (JIA)

Evaluation of the power of six clustering features in identifying a homogeneous disease subset in juvenile idiopathic arthritis (JIA)

Bibliographic Details
Main Authors:	Magnani A, Oliveira S, Castell E, Arguedas O, Ullmann N, Pederzoli S, Manzoni S Magni, Pistorio A, Ruperto N, Martini A, Ravelli A
Format:	Article
Language:	English
Published:	BMC 2008-09-01
Series:	Pediatric Rheumatology Online Journal

Similar Items

Time of onset of iridocyclitis (IC) in children with juvenile idiopathic arthritis (JIA)
by: Verazza S, et al.
Published: (2008-09-01)

Development and initial validation of the parent acceptable symptom state in juvenile idiopathic arthritis (JIA)
by: Filocamo G, et al.
Published: (2008-09-01)

A meta-analysis to estimate the “real” placebo effect in juvenile idiopathic arthritis (JIA) trials
by: Martini A, et al.
Published: (2011-09-01)

Final validation of a new composite disease activity score for juvenile idiopathic arthritis: the Juvenile Arthritis Disease Activity Score (JADAS)
by: Consolaro A, et al.
Published: (2008-09-01)

Analysis of ceiling effect and score distribution of outcome measures in juvenile idiopathic arthritis (JIA)
by: Lattanzi B, et al.
Published: (2008-09-01)

Impact of involvement of individual joint groups on subdimensions of functional ability scales in juvenile idiopathic arthritis
by: Meiorin S, et al.
Published: (2008-09-01)

Comparison of the accuracy of different definitions of clinical remission (CR) and minimal disease activity (MDA) in juvenile idiopathic arthritis (JIA)
by: Davì S, et al.
Published: (2008-09-01)

Agreement between objective and subjective definitions of inactive disease, remission and minimal disease activity in juvenile idiopathic arthritis
by: Davì S, et al.
Published: (2011-09-01)

Infliximab to treat chronic uveitis in juvenile idiopathic arthritis (JIA)
by: Bracaglia C, et al.
Published: (2008-09-01)

Parent and Patient Treatment Preferences in Juvenile Idiopathic Arthritis (JIA)
by: Montealegre Sanchez, Gina A.
Published: (2011)

Juvenile idiopathic arthritis (JIA): can an integrated medicine be possible?
by: Carlomagno R, et al.
Published: (2011-09-01)

Thalidomide: efficacy and side effects in juvenile idiopathic arthritis (JIA)
by: Alpigiani MG, et al.
Published: (2008-09-01)

Adalimumab and severe uveitis in juvenile idiopathic arthritis (JIA) therapy
by: Alpigiani MG, et al.
Published: (2008-09-01)

Mandibular condyle destruction in juvenile idiopathic arthritis (JIA)
by: Zak M, et al.
Published: (2008-09-01)

Talus Arthritis Pattern in Juvenile Idiopathic Arthritis (JIA)
by: Mohammad Alkhreisat MD, et al.
Published: (2019-10-01)

Comparison of physician's, parent's and patient's global ratings made on linear or 21-circle visual analogue scales (VAS) in juvenile idiopathic arthritis (JIA)
by: Dalprà S, et al.
Published: (2008-09-01)

14.4 Oligoarticular Juvenile Idiopathic Arthritis (JIA): can extension be predicted?
by: Hunter PJ, et al.
Published: (2008-09-01)

Replication of the association of the <it>COG6</it> gene with juvenile idiopathic arthritis (JIA)
by: Worthington J, et al.
Published: (2011-09-01)

Agreement between physicians and parents in rating functional ability of children with juvenile idiopathic arthritis
by: Buoncompagni Antonella, et al.
Published: (2007-12-01)

Investigating the use of a limited core outcome variable set for the classification of response following methotrexate treatment in juvenile idiopathic arthritis (JIA)
by: Hirani SP, et al.
Published: (2008-09-01)

4.4 Different phenotype of anaemia in systemic juvenile idiopathic arthritis (s-JIA) compared to anaemia in other subtypes of JIA
by: Hinze CH, et al.
Published: (2008-09-01)

How do parents of children with juvenile idiopathic arthritis (JIA) perceive their therapies?
by: Nageswaran Savithri, et al.
Published: (2008-06-01)

Immune regulation in health and Juvenile Idiopathic Arthritis (JIA) : molecular mechanisms and regulatory T cells
by: Pesenacker, A. M.
Published: (2013)

Current Treatments for Juvenile Idiopathic Arthritis
by: Alberto eMartini, et al.
Published: (2011-10-01)

Psoriasis and Temporomandibular Joint Involvement in Juvenile Idiopathic Arthritis (JIA) : A Longitudinal Study of the Nordic JIA Cohort
by: Ekelund, Maria
Published: (2020)

Rituximab in ANA positive polyarticular juvenile idiopathic arthritis (JIA) with uveitis
by: Baildam EM, et al.
Published: (2008-09-01)

Multicentric Castleman's Disease (CD) in juvenile idiopathic arthritis (JIA) treated with etanercept: coincidence or causal relationship?
by: Rossi L, et al.
Published: (2008-09-01)

An Economic Comparison of Treatment Strategies with Anakinra in Systemic Juvenile Idiopathic Arthritis (sJIA)
by: Bullement A, et al.
Published: (2021-09-01)

Notice of redundant publication: Aerobic capacity and disease activity in children, adolescents and young adults with juvenile idiopathic arthritis (JIA)
by: Martini Alberto, et al.
Published: (2013-01-01)

Children with juvenile idiopathic arthritis currently followed in a tertiary care setting have a better psychosocial well-being than healthy peers
by: Suffia C, et al.
Published: (2011-09-01)

Aerobic capacity and disease activity in children, adolescents and young adults with juvenile idiopathic arthritis (JIA)
by: van Pelt Philomine A, et al.
Published: (2012-08-01)

Aerobic capacity and disease activity in children, adolescents and young adults with juvenile idiopathic arthritis (JIA)
by: van Pelt Philomien A, et al.
Published: (2012-08-01)

Adalimumab treatment in Juvenile Idiopathic Arthritis (JIA) patients with special focus on Uveitis
by: Dehoorne J, et al.
Published: (2011-09-01)

Psychological characteristics of the patients with juvenile idiopathic arthritis (JIA) of various age groups
by: Stepanenko NY
Published: (2011-09-01)

Osteoblast differentiation from synovial fluid cells in juvenile idiopathic arthritis (JIA)
by: Jelusic-Drazic Marija, et al.
Published: (2012-07-01)

Investigating which variables from the core outcome variables in juvenile idiopathic arthritis (JIA) are the best predictors of classification as a responder to treatment with methotrexate (MTX)
by: Hirani SP, et al.
Published: (2008-09-01)

Efficacy and safety of tocilizumab (TCZ) in patients with systemic juvenile idiopathic arthritis (sJIA): TENDER 52-week data
by: De Benedetti Fabrizio, et al.
Published: (2012-07-01)

Knee disease in juvenile idiopathic arthritis (JIA): correlation between clinical and ultrasonographic findings
by: McCarron M, et al.
Published: (2008-09-01)

Anakinra in systemic juvenile idiopathic arthritis (soJIA) non responsive to antiTNF
by: Pontikaki I, et al.
Published: (2008-09-01)

Juvenile idiopathic arthritis (JIA) in two tertiary centres in the Western Cape, South Africa
by: Pope Chris, et al.
Published: (2011-09-01)